SOD1 and myocardial infarction: <b>Results:</b> CS-IVa improved cardiac function; reduced myocardial infarct size; attenuated histopathological injury; decreased serum CK-MB, cTnI, LDH and plasma MDA levels; and restored SOD activity in MIRI rats.